Dear Dr. Roach: I have had osteoporosis for a while and recently had a bone density test that again confirmed that I have it. I am not really interested in taking an oral prescription such as Fosamax, ...

DEAR DR. ROACH: I have had osteoporosis for a while and recently had a bone density test that again confirmed that I have it. I am not really interested in taking an oral prescription such as Fosamax, ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

Add Yahoo as a preferred source to see more of our stories on Google. Ozempic and other weight loss drugs are all the rage right now. However, some of the effects may not be the best for your health.

Aging and limited physical activity, as well as the use of novel weight loss drugs such as Wegovy and Zepbound, often lead to the simultaneous loss of muscle mass and bone density. Medications are ...

How Does Evenity Work for Osteoporosis? Throughout our lives, our bodies are constantly forming new bone and breaking down old bone. As we get older, the body begins to break down more bone than it ...

Research has shown there are plenty of perks of using a medication like Ozempic for weight loss. But, given that this is a drug, there are some potential downsides to consider, too. In case you’re not ...

Shares of the company fell more than 7% on Tuesday as analysts chewed over bone density loss data from an early-stage trial on the injection. One analyst said the additional data suggests a new ...

A widely prescribed thyroid medication called levothyroxine may cause bone loss and increase the risk of the bone disease osteoporosis, according to new research—but this does not mean Americans ...

GREENVILLE, S.C. (WSPA)– Nearly one in five women and one in twenty men, over the age of 50, are affected by osteoporosis, according to the Centers for Disease Control and Prevention. As part of our ...

On Tuesday, a Cantor analyst wrote that additional data from Amgen’s experimental weight loss injection, MariTide, suggests a new potential safety risk tied to the drug. Also Read: Jim Cramer Says Eli ...

Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.